Brief: Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results
07/11/2022 22:24
Nov 7 (Reuters) - Atea Pharmaceuticals Inc AVIR.O :
* ATEA PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* ATEA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nGNX8yWJqS
Further company coverage: AVIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM